Bluejay Diagnostics (BJDX) Interest Expenses (2024 - 2025)
Bluejay Diagnostics recorded quarterly Interest Expenses of $187.0 in Q4 2025, down 6.5% quarter-over-quarter from $200.0 in Q3 2025, and down 74.35% year-over-year from $729.0 in Q4 2024.
Bluejay Diagnostics' Interest Expenses history runs 2 years deep, the most recent figure standing at $187.0 for Q4 2025.
- In Q4 2025, Interest Expenses fell 74.35% year-over-year to $187.0; the TTM figure through Mar 2026 stood at $609.0 (down 99.93% YoY), while the FY2025 annual figure was $839.0, down 99.9% from the prior year.
- Interest Expenses came in at $187.0 for Q4 2025 at Bluejay Diagnostics, down from $200.0 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $626471.0 in Q2 2024 to a low of $187.0 in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 174.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 148.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 181.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 90.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -97.17 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 96.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 15.10 Mn |
| 10 | Bluejay Diagnostics | 572,394.44 | -3.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 187.00 |
| Dec 31, 2025 | 187.00 |
| Sep 30, 2025 | 200.00 |
| Sep 30, 2025 | 200.00 |
| Jun 30, 2025 | 222.00 |
| Jun 30, 2025 | 222.00 |
| Dec 31, 2024 | 729.00 |
| Dec 31, 2024 | 729.00 |
| Sep 30, 2024 | 190,610.00 |
| Sep 30, 2024 | 190,610.00 |
| Jun 30, 2024 | 626,471.00 |
| Jun 30, 2024 | 626,471.00 |